This inventor holds 1 USPTO granted patent. Top assignee: Array Biopharma Inc.. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: The Innovations of HongWoon Yang
Introduction
HongWoon Yang is a notable inventor based in Superior, Colorado. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific kinases involved in various diseases. His work is crucial in advancing treatments for pain, cancer, inflammation, neurodegenerative diseases, and certain infectious diseases.
Latest Patents
HongWoon Yang holds a patent for "Macrocyclic compounds as Trk kinase inhibitors." This patent includes compounds of Formula I and pharmaceutically acceptable salts thereof. The compounds are designed to inhibit Trk kinases, which play a vital role in the aforementioned diseases.
Career Highlights
Yang is currently associated with Array Biopharma Inc., a company known for its innovative approaches in drug development. His work at Array Biopharma has positioned him as a key player in the pharmaceutical industry, contributing to the advancement of therapeutic options for patients.
Collaborations
He collaborates with talented individuals such as Steven Wade Andrews and Kevin Ronald Condroski. These partnerships enhance the research and development efforts at Array Biopharma, fostering an environment of innovation and discovery.
Conclusion
HongWoon Yang's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to pave the way for new treatments that can significantly improve patient outcomes.
